IgG4-related Disease Clinical Trial
Official title:
Treatment of IgG4-Related Disease With Revlimid and Rituximab: The TIGR2 Trial
Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does combination therapy with rituximab and revlimid cause a sustained disease remission?
Immunoglobulin G subclass 4 Related Disease (IgG4-RD) is a recently recognized systemic fibroinflammatory condition. Various manifestations of IgG4-RD were previously recognized in individual organ systems, but these entities (including autoimmune pancreatitis, orbital pseudotumor, Reidel's thyroiditis, retroperitoneal fibrosis, idiopathic sialadenitis and dacryoadenitis, etc) are now recognized as manifestations of a common disease process that can affect any organ system. IgG4-RD is characterized by distinctive histologic findings of tissue infiltration by IgG4-positive plasma cells together with storiform fibrosis and obliterative phlebitis. Both clinical and pathologic consensus diagnostic criteria have been defined. Serum IgG4 concentration is a biomarker for IgG4-RD and is elevated in 70% to 90% of patients with active disease. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03368274 -
To Evaluate the Clinical Efficacy of Iguratimod in the Treatment of IgG4 Related Disease (IgG4-RD) With Mild Symptom
|
Phase 4 | |
| Not yet recruiting |
NCT03267875 -
A Laboratory Scan of Patients With Aortic Aneurysms to IgG4 Levels in the Blood
|
N/A | |
| Completed |
NCT02616705 -
Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis
|
||
| Completed |
NCT03669861 -
Safety and Efficacy of Abatacept in IgG4-Related Disease
|
Phase 2 | |
| Recruiting |
NCT05625581 -
Tofatib Treatment for IgG4-related Disease
|
||
| Recruiting |
NCT04125511 -
Characterizing IgG4-RD With 68Ga-FAPI PET/CT
|
Early Phase 1 | |
| Not yet recruiting |
NCT06285539 -
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
|
Phase 2 | |
| Not yet recruiting |
NCT05746689 -
Study of Sirolimus in IgG4-related Disease
|
N/A | |
| Completed |
NCT03690908 -
Infraorbital Nerve Involvement on Magnetic Resonance Imaging in IgG4-related Ophthalmic Disease
|
||
| Completed |
NCT02899039 -
Follicular Helper T Cells: Biological Marker and Involvement in the Physiopathology of the IgG4-related Disease
|
N/A | |
| Recruiting |
NCT04660565 -
Belimumab Treatment for IgG4-related Disease
|
Phase 4 | |
| Recruiting |
NCT01670695 -
A Prospective Cohort Study of IgG4RD in China
|
N/A | |
| Recruiting |
NCT03023371 -
National Registry of IgG4-RD in China
|
N/A | |
| Unknown status |
NCT01758393 -
Glucocorticoids in Patients With IgG4-RD
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03473912 -
Meir Medical Center Rheumatologic Biobank
|
||
| Not yet recruiting |
NCT03466970 -
Plasmablast Detection From IgG4-Related Disease Patients
|
N/A |